Wolfgang Bielke

Title: Wolfgang Bielke: Innovator in Nucleic Acid Research

Introduction

Wolfgang Bielke is a notable inventor based in Munich, Germany. He has made significant contributions to the field of nucleic acid research, particularly in the development of small interfering nucleic acids (siNAs). With a total of 2 patents to his name, Bielke's work has implications for gene silencing and apoptosis research.

Latest Patents

Bielke's latest patents include innovative approaches to modifying siNAs. The first patent focuses on the use of at least one abasic modification within the first eight nucleotide positions of the 5' region of the antisense strand of a siNA molecule. This modification aims to reduce off-target effects, providing suitable modified siNAs, compositions, and methods for their production. The second patent pertains to a positive control for expression modulating experiments, utilizing a combination of compounds that silence the expression of target genes involved in apoptosis. This invention also includes methods, kits, and compositions for effective application in research.

Career Highlights

Wolfgang Bielke is currently associated with Qiagen GmbH, a leading company in the field of molecular biology. His work at Qiagen has allowed him to further his research and contribute to advancements in nucleic acid technologies.

Collaborations

Bielke has collaborated with notable colleagues such as Jie Kang and Peter Hahn, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

Wolfgang Bielke's contributions to nucleic acid research through his patents and work at Qiagen GmbH highlight his role as an innovator in the field. His advancements in siNA technology are paving the way for future research and applications in gene silencing and apoptosis.